Specialty Pharmacy

Once-weekly pill has the potential to prevent 20% of new HIV infections.

Nearly all people who inject drugs with hepatitis C virus achieved a sustained virologic response at 12 weeks.

Mitochondrial inhibitors may be a beneficial add-on therapy for glioblastoma containing gene fusion.

Top news of the day from across the health care landscape.

Americans to walk, bike or run 7,000 miles during February bringing awareness to 7,000 rare diseases affecting 30 million Americans.

Insurers place more prior authorization requirements on PCSK9 inhibitors than other similar cholesterol treatments.

More than 60% of very elderly patients with stage 3 lung cancer did not receive treatment.

Consistent delivery of an electric field could drastically increase glioblastoma survival.

Tisagenlecleucel (Kymriah) under review to treat non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses what drove him to join the world of specialty pharmacy and the most rewarding part of it.

Top news of the day from across the health care landscape.

CDC notes link between jump in acute HCV cases and admissions to substance use disorder treatment facilities for opioid injections.

Patients with a high risk of recurrent breast cancer may not receive chemotherapy.

Sandoz proposed adalimumab biosimilar demonstrates similarity to reference product in safety, efficacy, and quality measures.

Novel HIV treatment protected immune cells against HIV for nearly a month.

More than one-third of HIV-positive patients are not vaccinated against hepatitis B virus.

FDA grants priority approval to arsenic trioxide (Trisenox) plus tretinoin for leukemia treatment.

Afatinib (Gilotrif) found to improve overall survival among patients with EGFR-mutated non-small cell lung cancer.

Top news of the day from across the health care landscape.

Automated HCV antigen testing has a much faster turnaround time and lower costs.

Important considerations for pharmacists to concerning the switch from a brand name biologic to a new biosimilar.

An investigational immunotherapy for multiple sclerosis targets Epstein-Barr virus.

The Maraba virus combined with an immune checkpoint inhibitor increased triple-negative breast cancer survival in mice.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, talks about the impact orphan drugs have had on the specialty pharmaceutical industry.

Certain hormonal forms of birth control could place women at a higher risk of contracting HIV.

Health care organizations show support for proposed Medicare Part D rules that require direct and indirect remuneration fees to be included at the point-of-sale.

Top news of the day from across the health care landscape.

Thus far there is no intervention that clearly reduces the risk of HCV infection from a mother to her child.